Amyloid-related imaging abnormalities (ARIA) in magnetic resonance imaging scans have emerged as indicators of potentially serious side effects in clinical trials of therapeutics for Alzheimer's disease. These anomalies include an edematous type (ARIA-E) that appears as hyperintense (bright) regions by T2-weighted MRI, and a type characterized by the deposition of hemosiderin (ARIA-H) that elicits a hypointense signal, especially in T2* and susceptibilityweighted imaging. ARIA in general has been linked to the presence of Aβ-type cerebral amyloid angiopathy, an accumulation of misfolded Aβ protein in the vascular wall that impairs the integrity of brain blood vessels. However, the pathobiology of ARIA remains poorly understood, in part due to the absence of an animal model of the disorder that would enable a contemporaneous analysis of tissue integrity in the affected region. Here we describe both ARIA-E and ARIA-H in an aged squirrel monkey (Saimiri sciureus), a nonhuman primate model of naturally occurring cerebral amyloid angiopathy. Histopathologic examination of the anomalous region revealed reactive astrocytosis and microgliosis, infiltration of systemic inflammatory/immune cells, damage to axons and myelin, and hemosiderin deposition. The disruption of axons in particular suggests that ARIA-E could have functional consequences for affected regions. The squirrel monkey model can be useful for studying the pathogenesis and long-term effects of ARIA, and for testing the safety and efficacy of emerging therapies for Alzheimer's disease.
Introduction
The accumulation of abnormally folded amyloid-β protein (Aβ) in the brain is an early and essential event in the pathogenesis of Alzheimer's disease (AD) [1] [2] [3] . A current experimental strategy to treat or prevent AD is active or passive immunization against Aβ [4] [5] [6] . The development of effective immunotherapies for AD, however, has been hindered by the appearance of anomalous magnetic resonance imaging (MRI) findings known as amyloid-related imaging abnormalities (ARIA) in some patients [7] [8] [9] [10] [11] [12] . ARIA can consist of edema (ARIA-E) or microhemorrhage-related hemosiderin deposition (ARIA-H) in the brain. Spontaneous ARIA-E has been detected infrequently in AD patients, but its incidence increases significantly in patients undergoing anti-Aβ immunotherapy and possibly also secretase inhibition in treatment trials for AD [13] . In many instances, ARIA-E is thought to reflect transient edema that is not associated with long-term changes such as a breakdown of tissue integrity, but little direct information exists to confirm or refute this assertion [13] .
Mounting evidence indicates that both ARIA-E and ARIA-H are associated with the presence of Aβ-type cerebral amyloid angiopathy (CAA) [13, 14] , in which the accumulation of misfolded Aβ in and around blood vessels impairs the vascular wall [14, 15] . CAA is present to some degree in nearly all AD patients [16] [17] [18] , and is severe in approximately 20% [19] [20] [21] . Anti-Aβ immunotherapy has been shown to reduce Aβ plaque load in AD patients [12, [22] [23] [24] and, later in the response to treatment, possibly CAA as well [14, 25] . In the first months following immunotherapy, postmortem histopathology suggests a redistribution of Aβ from the brain parenchyma to the vasculature [25] , potentially increasing the risk of hemorrhagic stroke. Studies in Aβ-precursor proteintransgenic mouse models have supported the assertion that anti-Aβ immunization can induce microvascular hemorrhage that is linked to CAA [8] , but ARIA per se has not been reported in rodent models.
Despite the problems that have beset immunotherapy trials, there have been hints that Aβimmunotherapy might be clinically beneficial in some AD patients [12, 22] , especially when administered early in the course of cognitive decline [26, 27] . ARIA is a potentially serious complication, however, and threatens to impede the development of disease-modifying therapies for AD [9, 20, 26] . The pathophysiology of ARIA remains poorly understood, in large part owing to the absence of a suitable animal model of the disorder [13] . In addition, because ARIA-E can be transitory in humans, there is little information on the histopathological basis of the imaging anomalies at the time the MRI is performed [13] . In the present study, we describe histopathological evidence for gliosis, inflammation, and white matter disruption by spontaneous ARIA-E and ARIA-H in an aged squirrel monkey, a nonhuman primate model of naturally occurring CAA [28] [29] [30] .
Materials and Methods

Subjects
Four female squirrel monkeys (Saimiri sciureus) with known birthdates were analyzed (Table) . Squirrel monkeys have a maximum lifespan of approximately 30 years [30, 31] ; they express human-sequence Aβ [32] and begin to deposit the protein in the brain at around 13 years of age [28] . Two 19-year-old squirrel monkeys were from the University of Texas MD Anderson Research Center in Bastrop, Texas, and two animals aged 13 and 16 years were from the Yerkes National Primate Research Center of Emory University in Atlanta, Georgia. All experiments were conducted at the Yerkes Center in accordance with the NIH Guidelines for the Ethical Care and Use of Animal Subjects, and were approved by the Emory University Institutional Animal Care and Use Committee (IACUC).
MRI Data Acquisition
The subjects were initially sedated with ketamine (15 mg/kg, i.m.), placed on a temperaturecontrolled heating pad, and anesthetized with ~1% isoflurane delivered via a nonrebreathing circuit. The head was immobilized with a custom head holder, and the animals were placed in the prone position during MRI scanning. All major physiological parameters were monitored continuously (heart rate, respiratory rate, blood pressure, body temperature, end-tidal CO2 [EtCO2], peripheral oxygen saturation [SpO2]) and maintained within normal ranges throughout the scan. Diffusion tensor imaging (DTI) data were acquired using a single-shot EPI sequence with the following imaging parameters: TE = 104 ms, TR = 5000 ms, data matrix = 60 × 74, voxel size = 1.1 mm × 1.1 mm, 30 slices with thickness 1.1 mm, a b-value of 1000 s/mm 2 and 30 diffusion-encoding directions. DTI data sets were acquired with identical imaging parameters except for reversed phase-encoding direction for correcting susceptibility-related image distortions.
MRI Analysis
MR images were visually evaluated on the MRI scanner console and further analyzed using ImageJ (http://rsb.info.nih.gov/ij/index.html). Examination of images began with the identification and quantification of MR signal irregularities, which were described based on morphology and anatomical location. Analyses were performed by at least two individual raters to ensure an accurate assessment of the entire brain of each subject. The initial examination focused on major structural alterations that would indicate a significant pre-existing condition (such as tumors or major infarcts), of which none were found. Subsequently, all images were inspected for the presence of abnormal MRI signals, which were defined a priori as being at least one mm in diameter (in-plane resolution) and being present in a minimum of three adjacent slices of the whole brain MRI. Once an anomaly was identified, its anatomical location, extent and nature were recorded for comparison to other MR modalities and to the histological brain sections.
DTI data were processed with FSL toolbox (FMRIB, Oxford). Susceptibility-related distortions in DTI data were corrected with TOPUP script in FSL. Diffusion-weighted imaging (DWI) representations were calculated by averaging the images of all 30 diffusion directions. Fractional anisotropy (FA), mean diffusivity (MD), and vector maps (showing the principal diffusion tensor direction) were calculated and displayed with FSL scripts.
Tissue Preparation and Histology
Immediately following in vivo imaging, the subjects were sedated with ketamine (15 mg/kg, i.m.), given an overdose of sodium pentobarbital (100 mg/kg i.v.), and, under deep anesthesia, transcardially perfused with cool (4-8°C), filtered phosphate-buffered saline (PBS) (pH 7.4) followed by 10% neutral buffered formalin (NBF). The brain was removed and post-fixed in 10% NBF for a minimum of one week. All brains were grossly normal and devoid of obvious external indications of disease or injury.
Brains were blocked into four coronal slabs, matching as closely as possible the slice plane in the MRI, and then cryoprotected for one week in 30% sucrose dissolved in PBS. The slabs were frozen on dry ice, and coronal sections were cut on a Microm HM 430 freezingsliding microtome at 40μm thickness. Systematically selected sections were stained with hematoxylin & eosin (H&E), Perls' stain for ferric iron, thioflavin-S for amyloid, Luxol Fast Blue for myelin, or immunohistochemically for the following antigens: Aβ1-16 (antibody 6E10, Covance, Princeton, NJ), glial fibrillary acidic protein (GFAP) for astrocytes (Boehringer Mannheim, Indianapolis, IN), ionized calcium-binding adapter molecule 1 (IBA-1) for microglia (Wako Chemicals USA, Richmond, VA), CD68 for macrophages (Dako, Carpinteria, CA), CD3 for T lymphocytes (Abcam, Cambridge, MA), SMI-31 for phosphorylated neurofilaments (Covance), or CP13 for phospho-tau 202 (courtesy of Dr. Peter Davies, Feinstein Institute for Medical Research, Manhasset, NY, USA). Primary antibodies were detected using the avidin-biotin peroxidase method (Vectastain Elite ABC kits, Vector Laboratories, Burlingame, CA).
Immunostaining consisted of incubating tissue in 1% H 2 O 2 for 30 minutes, then in 0.3% Triton X-100 for 10 minutes and 5% blocking serum for 30 minutes, all in Tris-buffered saline (TBS). Immunodetection of Aβ was enhanced by pre-treatment of the sections with formic acid (no other antigen required this step). Tissue was incubated with primary antibodies in TBS at 4°C, overnight. The following day, the tissue was washed in TBS and the antigens visualized with the ABC method using 3,3′-diaminobenzidine (DAB) as the chromogen. Some sections were counterstained with hematoxylin. Light-microscopic images were captured with an Aperio scanner (Leica Biosystems, Buffalo Grove, IL), a Leica DMLB microscope (Leica, Wetzlar, Germany) equipped with a Spot Flex digital camera (Diagnostic Instruments, Sterling Heights, MI), or with a Nikon Labophot microscope (Tokyo, Japan) equipped with a Moticam 2500 camera (Vancouver, British Columbia, Canada). Aβ-immunoreactive parenchymal (plaque) and vascular (CAA) deposits were quantitatively assessed on a scale of 0 (none) to 4 (heavy) by consensus of three independent observers using photos of the different stages as standards.
Results
MRI of ARIA-E and ARIA-H
In the parieto-occipital lobes of 19-year-old squirrel monkey 2266, in vivo MR imaging revealed large, bilaterally asymmetric signal abnormalities that were consistent with ARIA-E and ARIA-H (Figures 1, 2) . The ARIA-E-like T2-weighted signal hyperintensity encompassed the dorsomedial parieto-occipital white matter and (to a lesser extent) the gray matter of both hemispheres for approximately 8 mm in the rostrocaudal axis. T1-weighted structural images corresponding to the T2 hyperintense region demonstrated reduced white matter definition throughout the affected zone ( Figure 2 ). Diffusion-weighted imaging showed evidence of increased mean diffusivity ( Figure 1B) in the anomalous area. Affected sites had a corresponding reduction in fractional anisotropy ( Figure 1C ) and white matter directionality ( Figure 1D ) compared to the same regions in an unaffected animal of similar age (2276). Susceptibility-weighted imaging disclosed signal hypointensities consistent with ARIA-H that partially overlapped with the ARIA-E signal in the dorsal parieto-occipital lobes (Figure 2 ). Multiple MR modalities disclosed no similar signal abnormalities elsewhere in the brain, nor were any found in the other three animals analyzed.
Histopathologic Features of ARIA-E and ARIA-H
Aβ immunohistochemistry and thioflavin-S staining detected species-typical CAA throughout much of the forebrain in the affected animal (2266). In the region of the parietooccipital lobes exhibiting signal anomalies by MRI, numerous amyloidotic large vessels were evident in the sulci, as were amyloidotic large and small vessels within the brain parenchyma (Figures 3,7 ). Compared to unaffected regions ( Figure 4E,4G) , the T2-weighted hyperintense ARIA-E region was marked by pronounced astrocytic and microglial hypertrophy ( Figure 4D ,4F) in the white matter and (to a lesser degree) the gray matter. Immunostaining for phosphorylated neurofilaments and Luxol Fast Blue staining of myelin showed evidence of axonal abnormalities and disruption of white matter integrity in the involved area ( Figure 5 ).
The parieto-occipital sulcus (the caudomedial extension of the lateral cerebral fissure) was somewhat expanded and partly occupied by an abnormal cell-rich matrix that surrounded sulcal and penetrating blood vessels ( Figure 6 ). Many of the vessels were immunoreactive for Aβ (Figure 7) , and the penetrating branches exhibited characteristic cuffing by cells that were continuous with those in the sulcal material ( Figure 6C ), indicative of focal angiitis [33] . The cellular matrix contained profuse CD68-immunoreactive macrophages ( Figure 6F ) and CD3-positive lymphocytes ( Figure 6G ). The sulcal substance was accompanied by ferric iron-reactive hemosiderin ( Figure 6D ) that surrounded CAA-positive blood vessels ( Figure  6E ) and co-localized with the rostro-caudal extent of the hypointense MR signals detected by SWI.
In the oldest of the three other squirrel monkeys (animal 2276), the degree of CAA was similar to that in the ARIA-affected animal, whereas in the younger monkeys (2504 and 3237), CAA was less profuse (Table) . None of the other animals showed ARIA-type imaging abnormalities or significant histopathological lesions, except for the presence of Aβ deposits. Periventricular white matter hyperintensities, as have been reported in humans with CAA [34] , were not evident in any of the four subjects. None of the animals displayed evidence of sensorimotor deficits, but systematic behavioral testing that might have revealed subtle cognitive or sensory deficits was not undertaken.
Discussion
Amyloid-related imaging abnormalities are a significant impediment to the development of effective therapies for Alzheimer's disease [13] . To date, despite the availability of numerous genetically modified mouse models of AD-like pathology, no suitable model of ARIA has been identified. Here we describe an aged squirrel monkey with naturally occurring ARIA-E and ARIA-H that are linked histopathologically to CAA, gliosis, inflammation, iron deposition, and axonal abnormalities. The disruption of axons in particular indicates that ARIA-E may have significant, and possibly long-term, functional consequences for brain areas interconnected by the affected axons.
Earlier investigations showed that aging squirrel monkeys are particularly vulnerable to CAA [28] [29] [30] , usually beginning around the age of 13 years [28] . In our experience, some degree of CAA is always present in squirrel monkeys after 15 years of age, and by the late teens it is severe and widespread, especially in the neocortex [29] . It is possible that ARIA is infrequent in normal aged squirrel monkeys, even when CAA is present; furthermore, some ARIA-E events might escape detection due to their apparently transient nature [13] . However, given the connection between ARIA and CAA in humans [13, 14] , and the heightened incidence of ARIA in therapeutic trials of Aβ-immunotherapy [10, 12, 26, 35] , the squirrel monkey could be a sensitive in vivo model for testing the safety of such therapies and for assessing possible long-term consequences arising from transient ARIA-E [13] .
Along with CAA, the ARIA-affected brain region was marked by pronounced inflammation that included reactive gliosis in the parenchyma as well as infiltration of macrophages and lymphocytes into both the parenchyma and adjacent sulcus. In humans, idiopathic CAArelated inflammation is a rare disorder [36, 37] that manifests in various ways [38] and has been given a number of monikers, such as Aβ-related angiitis (ABRA), cerebral amyloid inflammatory vasculopathy, and others [39] . CAA-related inflammation in humans involves the incursion of inflammatory cells [36] , and in many (but not all) cases, CAA-related inflammation responds favorably to immunosuppressive agents [36, 39, 40] . The extent to which the cellular inflammatory reaction per se contributes to the aberrant MRI signal hyperintensities in T2-weighted scans (as opposed to the contribution of vasogenic edema alone) is unknown. We also cannot know with certainty if the edematous imaging abnormality in the aged squirrel monkey represents a chronic process that is unrelated to the vascular amyloid. Experimental induction of ARIA-E in the squirrel monkey model, e.g., by administration of certain anti-Aβ antibodies, might help to gauge the contribution of inflammatory cells both to the MR signal abnormality and to the disruption of tissue integrity. Furthermore, the timecourse of changes can be systematically monitored in the model, including behavioral proficiency and potential biomarkers in the CSF and blood. The model may also aid in determining why some ARIA patients suffer from significant cognitive impairment following treatment with anti-inflammatory/immunosuppressive agents [38, [41] [42] [43] [44] .
In humans, increased CAA and spontaneous ARIA have been associated with the apolipoprotein E-ε4 (APOE4) allele [14, 45] . In addition, All nonhuman primates studied thus far are homozygous for APOE4 according to the standard (human) nomenclature, although a threonine rather than arginine at amino acid position 61 is thought to cause nonhuman primate ApoE4 to function similarly to ApoE3 [46] , the most common human isoform. Further work is needed to determine whether the nonhuman primate type of ApoE4, which presumably is the ancestral form of the protein [47, 48] , is a risk factor for CAA and ARIA.
Age-related cerebral Aβ deposition has been reported in several nonhuman primate species [49, 50] and in other mammals such as senescent dogs [51, 52] . Because CAA is common in many of these species [29, 30, 51, 53] , it might be fruitful to determine whether they also are susceptible to ARIA in old age or as a result of experimental therapies.
Advances in high-field MRI techniques have continually lowered the threshold for detection of cerebrovascular abnormalities and their sequelae, but few studies have been able to determine the concurrent neuropathological correlates of ARIA-related changes, especially in the case of ARIA-E. The interpretation of MRI irregularities in humans is confounded by the often long interval between detection of ARIA in the living patient and subsequent histological assessment of tissue integrity in the region at autopsy. Additional obstacles to correlative analysis are long and variable postmortem intervals, the lack of consistency in tissue processing and fixation, and selection bias in the performance of autopsies. The limited information linking MRI signal anomalies to neuropathology has tended to rely largely on ex vivo imaging of postmortem brains, which may yield results that differ from those achieved in vivo, particularly with regard to edematous regions such as ARIA-E. For example, while T1-weighted scans are the standard for in vivo structural imaging, these same modalities do not yield reliably interpretable images when used on fixed tissue [54] . Sequential MR analysis of squirrel monkey brains in vivo and ex vivo can be used to determine the validity of ex vivo imaging of tissues from human subjects. An additional advantage of the squirrel monkey model is that the pathologic basis of MR imaging anomalies detected in vivo can be ascertained in near-real time.
model of CAA and ARIA, the aged squirrel monkey could help to establish the probable nature and long-term consequences of ARIA in AD patients undergoing therapies designed to reduce the cerebral burden of aggregated Aβ [12] , and to develop strategies for mitigating the impact of ARIA on the brain. In the region of the right-hemispheric SWI hypointensity (to the right of the asterisk in panel A) in animal 2266, an abnormal cell-rich matrix is present in the parieto-occipital sulcus (shown at low magnification in B and higher magnification in C; hematoxylin and eosin stain). Note the perivascular accumulation of leukocytes (cuffing) around blood vessels penetrating the parenchyma of the brain (2 cuffed vessels are indicated by arrowheads in C; their intense bluish appearance denotes the presence of abundant, hematoxylin-stained inflammatory cells). Panel D shows hemosiderin deposition (blue) surrounding a sulcal blood vessel in the ARIA-H region (Perls' stain for ferric iron), and panel E shows the same vessel immunostained for Aβ (antibody 6E10). Panel F shows CD68-immunoreactive macrophages and panel G shows CD3-reactive T-lymphocytes in the sulcal matrix and An Aβ-immunoreactive sulcal blood vessel (arrow) is partially embedded in an abnormal matrix consisting largely of immune/inflammatory cells (material just below the vessel; see also Figure 6 ) in the ARIA-affected area of animal 2266; two immunoreactive penetrating vessels are denoted by arrowheads, and a number of Aβ-immunoreactive capillaries are present in the cortical parenchyma. Antibody 6E10; Bar = 400μm. The extent of Aβ-immunoreactive lesions in the cerebral vasculature (CAA) and parenchyma (Aβ plaques) in the analyzed cohort of squirrel monkeys. Lesion load was determined by consensus of three independent observers using photographs as standards for the stages of deposition. 
